Literature DB >> 10964595

Poly(ADP-ribose) polymerase-1 in the nervous system.

H C Ha1, S H Snyder.   

Abstract

Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear enzyme, activated by DNA strand breaks to participate in DNA repair. Overactivation of PARP by cellular insults depletes its substrate NAD(+) and then ATP, leading to a major energy deficit and cell death. This mechanism appears to be prominent in vascular stroke and other neurodegenerative processes in which PARP gene deletion and PARP-inhibiting drugs provide major protection. Cell death associated with PARP-1 overactivation appears to be predominantly necrotic while apoptosis is associated with PARP-1 cleavage, which may conserve energy needed for the apoptotic process. Novel forms of PARP derived from distinct genes and lacking classic DNA-binding domains may have nonnuclear functions, perhaps linked to cellular energy dynamics. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964595     DOI: 10.1006/nbdi.2000.0324

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  44 in total

1.  Medulloblastoma in mice lacking p53 and PARP: all roads lead to Gli.

Authors:  Charles G Eberhart
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

2.  Muscarinic receptor activation protects cells from apoptotic effects of DNA damage, oxidative stress, and mitochondrial inhibition.

Authors:  Patrizia De Sarno; Svetlana A Shestopal; Taj D King; Anna Zmijewska; Ling Song; Richard S Jope
Journal:  J Biol Chem       Date:  2003-01-21       Impact factor: 5.157

3.  Inhibitory effects of adenine nucleotides on brain mitochondrial permeability transition.

Authors:  Angela Saito; Roger F Castilho
Journal:  Neurochem Res       Date:  2010-07-22       Impact factor: 3.996

4.  Ribosome-inactivating protein and apoptosis: abrin causes cell death via mitochondrial pathway in Jurkat cells.

Authors:  Sriram Narayanan; Avadhesha Surolia; Anjali A Karande
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

5.  Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.

Authors:  Elliot J Glotfelty; Thomas Delgado; Luis B Tovar-Y-Romo; Yu Luo; Barry Hoffer; Lars Olson; Tobias Karlsson; Mark P Mattson; Brandon Harvey; David Tweedie; Yazhou Li; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2019-02-11

6.  Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration.

Authors:  H C Ha; K Juluri; Y Zhou; S Leung; M Hermankova; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

7.  IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis.

Authors:  Adam I Kaplin; Deepa M Deshpande; Erick Scott; Chitra Krishnan; Jessica S Carmen; Irina Shats; Tara Martinez; Jennifer Drummond; Sonny Dike; Mikhail Pletnikov; Sanjay C Keswani; Timothy H Moran; Carlos A Pardo; Peter A Calabresi; Douglas A Kerr
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

Review 8.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

9.  Vitamin A depletion causes oxidative stress, mitochondrial dysfunction, and PARP-1-dependent energy deprivation.

Authors:  Haw-Jyh Chiu; Donald A Fischman; Ulrich Hammerling
Journal:  FASEB J       Date:  2008-08-01       Impact factor: 5.191

10.  Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons.

Authors:  Dong Liu; Robert Gharavi; Michael Pitta; Marc Gleichmann; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2009-03-14       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.